Overview

Long-Term Safety, Tolerability and Efficacy in Perampanel Treated Parkinson's Disease Patients With Motor Fluctuations

Status:
Terminated
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
A 48-month open label multi-centered extension study to evaluate the long-term safety, tolerability and efficacy of E2007 in patients with Parkinson's Disease with "wearing off" motor fluctuations and "on" period Dyskinesias.
Phase:
Phase 2
Details
Lead Sponsor:
Eisai Inc.